Welcome to LookChem.com Sign In|Join Free
  • or
2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(1-naphthalenyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

61595-16-2

Post Buying Request

61595-16-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

61595-16-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 61595-16-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,5,9 and 5 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 61595-16:
(7*6)+(6*1)+(5*5)+(4*9)+(3*5)+(2*1)+(1*6)=132
132 % 10 = 2
So 61595-16-2 is a valid CAS Registry Number.

61595-16-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2,4-dihydroxyphenyl)-3-naphthalen-1-ylprop-2-en-1-one

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:61595-16-2 SDS

61595-16-2Downstream Products

61595-16-2Relevant academic research and scientific papers

Synthesis of butein analogues and their anti-proliferative activity against gefitinib-resistant non-small cell lung cancer (NSCLC) through Hsp90 inhibition

Seo, Young Ho,Jeong, Ju Hui

supporting information, p. 1294 - 1298 (2014/06/09)

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer representing 85% of lung cancer patients. Despite several EGFR-targeted drugs have been developed in the treatment of NSCLC, the clinical efficacy of these EGFR-targeted therapies i

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 61595-16-2